TNF Pharmaceuticals Inc. Ordinary Shares TNFA 深 沪
已收盘 09-12 16:00:00 美东时间
3.89
-0.150
-3.71%
华盛通- 最 高4.04
- 今 开3.90
- 成交量 24.20万股
- 最 低 3.75
- 昨 收 4.04
- 总市值 694.83万
- 52周最高 195.00
- 市盈率 静 --
- 换手率 13.55%
- 52周最低 3.24
- 委 比 11.23%
- 总股本 178.62万
- 历史最高 6566400.00
- 量 比 0.49
- 振 幅 7.18%
- 历史最低 3.75
- 每 手 1
- 风险率 3.02%
个股概要
财务分析
公司资料
相关新闻
分红派息
- 分时图
- 日k
- 周k
- 月k
相关新闻
更多TNF Pharmaceuticals Secures $7M in Private Placement
TNF Pharmaceuticals ( ($TNFA) ) just unveiled an update. On September 4, 2025, ...
09-11 05:33
12 Health Care Stocks Moving In Tuesday's After-Market Session
Gainers Revelation Biosciences (NASDAQ:REVB) stock moved upwards by 7.7% to $2...
09-10 05:06
TNF Pharmaceuticals Enters Licensing Agreement with LightSolver
TNF Pharmaceuticals ( ($TNFA) ) has shared an announcement. On September 2, 202...
09-02 21:48
PharmaCyte Biotech Invests Additional $3M In TNF Pharmaceuticals To Support LightSolver Partnership
TNF new strategic partner LightSolver named a 2025 World Economic Forum Technology Pioneer and recognized in Gartner's 2025 Hype Cycle for Data Center Infrastructure TechnologiesPharmaCyte Biotech, Inc. (NASDAQ:PMCB)
09-02 21:22
TNF Pharmaceuticals to execute reverse stock split
TNF Pharmaceuticals (NASDAQ:TNFA) plans to execute a reverse stock split of its common stock at a ratio of 1 post-split share for every 100 pre-split shares to obtain compliance with Nasdaq's listing ...
08-28 21:28
TNF Pharma Announces 1-For-100 Reverse Stock Split Effective Sept. 2; Operational Updates Expected Post-Split
TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today announced that its
08-28 21:20
Why MongoDB Shares Are Trading Higher By 31%; Here Are 20 Stocks Moving Premarket
Shares of MongoDB, Inc. (NASDAQ:MDB) rose sharply in pre-market trading after t...
08-27 18:05
TNF Pharmaceuticals Q2 EPS $(0.18) Up From $(4.54) YoY
TNF Pharmaceuticals (NASDAQ:TNFA) reported quarterly losses of $(0.18) per share. This is a 96.04 percent increase over losses of $(4.54) per share from the same period last year.
08-20 05:54
TNF Pharmaceuticals Improves Its Financial Position Over The Past 5 Months Through A Material Reduction In Liabilities, While Maintaining Total Assets Of Over $17M As Of June 30, 2025
TNF Pharmaceuticals, Inc. (NASDAQ:TNFA) ("TNF" or the "Company"), a clinical stage biopharmaceutical company committed to developing novel therapies for autoimmune and inflammatory conditions, today announced that is has
08-20 05:22
12 Health Care Stocks Moving In Friday's After-Market Session
Gainers DIH Holding US (NASDAQ:DHAI) shares rose 35.1% to $0.34 during Friday'...
07-19 05:06
